Exploratory Clinical Neuroscience Research Service

The government authority in Washington, DC requires a vendor to provide exploratory clinical neuroscience research services offsite. The buyer needs research investigating individual differences in neural circuitry underpinning substance use disorder (SUD)-related behavior and outcomes, including the neurobiology of risk factors such as stress reactivity. Requested scope includes studying behavioral or cognitive processes and their neurobiological mechanisms as variables in substance use stages, characterizing SUD transition points, and utilizing neurobiological signatures to predict compulsive intake. Additionally, the vendor must conduct behavioral and neurobiological phenotyping for risk and protection, identify malleable neural circuitry for preventative interventions, and execute complex multidimensional behavioral phenotyping. Only onshore USA organizations are eligible for this opportunity. The buyer seeks proposals for the budget and provides no key dates or specific evaluation criteria in the source text.